logo
'Modern Family' star Julie Bowen opens up about heart disorder, 'Happy Gilmore 2' role

'Modern Family' star Julie Bowen opens up about heart disorder, 'Happy Gilmore 2' role

Yahooa day ago
Julie Bowen is opening up about the heart condition that led her to receive a pacemaker at age 29.
In an appearance on the "Inside of You" podcast released on Tuesday, July 1, the "Modern Family" star, 55, discussed being diagnosed with sick sinus syndrome, a heart disorder that caused her to have a low heart rate.
Bowen noted she was diagnosed soon after graduating college thanks to her sister, who was in medical school at the time. The actress always had a low heart rate, but when her sister listened to it with a stethoscope, she told Bowen, "You need to go to a cardiologist immediately."
Bowen subsequently received her diagnosis and got a pacemaker under her armpit, right after shooting the pilot of her early 2000s NBC series, "Ed."
"I was like, 'Oh my God. My life is over. This is so weird. I'm going to die.' I don't know what I thought it was," Bowen said. "I was 29 years old."
'Modern Family' star Julie Bowen clears up that viral hiker rescue story: 'I did nothing'
The actress explained the condition would give her a feeling of lightheadedness − as if she had been holding her breath − whenever she was relaxed. Before receiving her pacemaker, which she has had replaced a few times since, doctors warned that this could result in Bowen passing out while behind the wheel of a car and causing an accident.
According to the Mayo Clinic, sick sinus syndrome is a kind of heart rhythm disorder that causes heartbeats that are "too fast, too slow, interrupted by long pauses — or an alternating combination of these rhythm issues." The condition is "relatively uncommon."
"The risk of developing it increases with age," the clinic notes. "Many people with sick sinus syndrome eventually need an implanted device called a pacemaker to keep the heart in a regular rhythm."
'Modern Family' cast share emotions of last script reading: 'I was sobbing'
Bowen previously discussed the condition in a 2011 interview with WebMD. She said at the time that her pacemaker "serves as a monitor for me," adding that she is grateful "to live during a time when the technology exists to treat my condition."
She also noted that she doesn't "hear or feel" the device.
In fact, when Bowen's pacemaker was brought up on the "Inside of You" podcast, she said, "That's right. I forget about that all the time."
During her "Inside of You" appearance, Bowen also reflected on reprising her "Happy Gilmore" character Virginia Venit in the upcoming sequel "Happy Gilmore 2." The actress said she was initially surprised there was still interest in featuring Venit, a pro golf tour public relations director who becomes the romantic interest of Adam Sandler's Happy Gilmore.
"I didn't think they'd bring me back at all," Bowen said. "I mean, who am I supposed to be? He's got to have a younger woman in this one." Although Bowen reportedly has a smaller role, she said Sandler encouraged her that Venit is "the heart of the movie."
"Happy Gilmore 2," set for a July 25 release, will also include appearances from Christopher McDonald and Ben Stiller, who played Shooter McGavin and Hal L., respectively, in the 1996 cult comedy classic. The star-studded cast is rounded out with additional performances by "The Substance" actress Margaret Qualley, reggaeton singer Bad Bunny, rap superstar Eminem and NFL player Travis Kelce.
10 bingeable memoirs to check out: Celebrities tell all about aging, marriage and Beyoncé
Despite her starring role in the original "Happy Gilmore," Bowen said she didn't anticipate landing the gig because she thought filmmakers were looking for a "hot girl" to portray Venit.
"I read, and they were relieved," Bowen recalled of her audition. "They were visibly relieved. I go, 'What's going on?' They're like, 'Yeah, some of these girls are just so aggressively sexy.' And I was like, 'That's a bad thing?' I thought you guys liked that."
(This story was updated to add new information.)
Contributing: Edward Segarra, USA TODAY
This article originally appeared on USA TODAY: Julie Bowen discusses heart disorder, 'Happy Gilmore 2' role
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UnitedHealth Under Fire as Medicaid & Centene Bombshell Rattle Sector
UnitedHealth Under Fire as Medicaid & Centene Bombshell Rattle Sector

Yahoo

time34 minutes ago

  • Yahoo

UnitedHealth Under Fire as Medicaid & Centene Bombshell Rattle Sector

UnitedHealth Group Incorporated UNH continues to face challenges amid a turbulent healthcare insurance landscape. The passage of the 'One Big Beautiful Bill Act' through Congress, ready for President Donald Trump's signature, threatens to significantly reduce federal Medicaid spending. According to reports, approximately 11.8 million Americans are expected to lose Medicaid coverage by 2034, with 5.2 million affected by new work requirements alone. To curb state-level Medicaid expenditures, the bill gradually limits the use of 'provider taxes' as a revenue source. However, it also allocates $50 billion in funding to support rural hospitals impacted by these cuts. While insurers like UnitedHealth and Humana Inc. HUM may encounter short-term pressure from shrinking Medicaid rolls, they could ultimately benefit as displaced members shift toward private coverage options. UnitedHealth's Medicaid membership declined 4% in 2023, 5.2% in 2024, and 1.4% in the first quarter of 2025. The proposed elimination of ACA marketplace tax credits will likely propel more people into employer-sponsored plans. Meanwhile, Medicare Advantage may gain traction, as seniors grapple with increased out-of-pocket expenses due to rollbacks in Medicare Savings Programs. UnitedHealth's Medicare Advantage enrollment rose by 8.3% in 2023, 1.9% in 2024, and 6.3% in the first quarter of 2025. Another major development shook the market as Centene Corporation CNC, a major Medicaid player, withdrew its 2025 earnings guidance late Tuesday, citing unexpected enrollment shifts and higher medical costs. The move, mirroring UnitedHealth's earlier decision, rattled the managed care sector. Centene shares witnessed massive declines following the news, and peers like UnitedHealth and Humana followed suit. Centene shares plummeted 41.2% following the announcement, dragging down peers: UnitedHealth and Humana dropped 5.4% and 5.1%, respectively, despite broader market gains driven by tech strength and encouraging jobs data. Image Source: Zacks Investment Research From a valuation standpoint, UnitedHealth trades at a forward price-to-earnings ratio of 12.99, up from the industry average of 11.49. UNH currently carries a Value Score of A. Image Source: Zacks Investment Research The Zacks Consensus Estimate for UnitedHealth's 2025 earnings is pegged at $22.07 per share, implying a 20.2% drop from the year-ago period. Image Source: Zacks Investment Research The stock currently carries a Zacks Rank #5 (Strong Sell). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report Humana Inc. (HUM) : Free Stock Analysis Report Centene Corporation (CNC) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio

Investors in OptimizeRx (NASDAQ:OPRX) have unfortunately lost 55% over the last three years
Investors in OptimizeRx (NASDAQ:OPRX) have unfortunately lost 55% over the last three years

Yahoo

timean hour ago

  • Yahoo

Investors in OptimizeRx (NASDAQ:OPRX) have unfortunately lost 55% over the last three years

It is doubtless a positive to see that the OptimizeRx Corporation (NASDAQ:OPRX) share price has gained some 73% in the last three months. But that is small recompense for the exasperating returns over three years. Indeed, the share price is down a tragic 55% in the last three years. Some might say the recent bounce is to be expected after such a bad drop. While many would remain nervous, there could be further gains if the business can put its best foot forward. It's worthwhile assessing if the company's economics have been moving in lockstep with these underwhelming shareholder returns, or if there is some disparity between the two. So let's do just that. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. Because OptimizeRx made a loss in the last twelve months, we think the market is probably more focussed on revenue and revenue growth, at least for now. Generally speaking, companies without profits are expected to grow revenue every year, and at a good clip. That's because fast revenue growth can be easily extrapolated to forecast profits, often of considerable size. Over three years, OptimizeRx grew revenue at 16% per year. That's a fairly respectable growth rate. So some shareholders would be frustrated with the compound loss of 16% per year. The market must have had really high expectations to be disappointed with this progress. So this is one stock that might be worth investigating further, or even adding to your watchlist. The image below shows how earnings and revenue have tracked over time (if you click on the image you can see greater detail). We consider it positive that insiders have made significant purchases in the last year. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. So we recommend checking out this free report showing consensus forecasts It's good to see that OptimizeRx has rewarded shareholders with a total shareholder return of 34% in the last twelve months. Notably the five-year annualised TSR loss of 1.3% per year compares very unfavourably with the recent share price performance. The long term loss makes us cautious, but the short term TSR gain certainly hints at a brighter future. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Take risks, for example - OptimizeRx has 1 warning sign we think you should be aware of. If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: most of them are flying under the radar). Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

The heat has a surprising effect on the brain — here's what doctors want you to know
The heat has a surprising effect on the brain — here's what doctors want you to know

Fox News

timean hour ago

  • Fox News

The heat has a surprising effect on the brain — here's what doctors want you to know

Summer heat has swept the U.S., with warnings issued across the East Coast and Midwest. In addition to putting stress on the body, hot weather can also take a toll on the brain and mental health. Dr. Jace Reed, director of emergency psychiatry at Cedars-Sinai Hospital in Los Angeles, emphasized in an interview with Fox News Digital that the brain is a major organ that can be greatly affected by heat. Extreme heat can cause mental health changes like increased irritability and anxiety, along with decreased memory, attention and reaction time. This can affect daily interactions socially and professionally, the expert cautioned. "You may be slower at completing your task or remembering what someone just told you," he told Fox News Digital. "Those can be initial early signs that the heat is affecting your brain and your mental abilities." Symptoms like extreme confusion could mark the beginning of a heat stroke, which could require hospitalization, the psychiatrist warned. In a separate interview with Fox News Digital, Thea Gallagher, a doctor of psychology and director of wellness programs at NYU Langone Health, noted that when the body overheats, it struggles to regulate internal balance. This can lead to disrupted sleep, fatigue and poor concentration, as well as impaired cognitive function, slow reaction times and struggles with decision-making. The heat can also increase oxidative stress and inflammation in the brain, Gallagher added, which can potentially damage neurons, worsen existing neurological conditions and raise stroke risk. "Heat exposure may trigger an inflammatory response in the brain," she said. "In cases like heatstroke, inflammation is believed to contribute to symptoms such as confusion and delirium." Excessive heat can also weaken the protective blood-brain barrier, according to the expert, which makes the brain more vulnerable to toxins and pathogens. Higher temperatures are also associated with disturbances in mood and violent behavior, especially during prolonged heatwaves. Psychiatric emergency visits for anxiety, depression and substance use also rise significantly on the hottest days, Gallagher confirmed. Below are some of the main mental symptoms that can worsen in hot weather, experts cautioned. People who suffer from mental health conditions such as mood disorders, schizophrenia, anxiety or even dementia are more vulnerable in hot weather. Some psychiatric medications could make it difficult for the body to regulate temperature or stay hydrated, Gallagher noted, while heat can "intensify" symptoms like agitation or paranoia. "People with cognitive impairments may not recognize the signs of overheating," she added. "Some SSRIs (selective serotonin reuptake inhibitors) can suppress sweat production, which is the body's primary cooling mechanism. This raises the risk of overheating, dehydration and even heat stroke." "Paradoxically, SSRIs can also cause excessive sweating in some individuals — a side effect known as 'SSRI sweats,'" she went on. "While this might seem like it would help with cooling, it can actually lead to dehydration if fluid intake doesn't keep up." The experts recommended the following practices to protect brain health in extreme heat. For more Health articles, visit "Days are also longer and there are more activities, which can be exhausting," Gallagher noted. "Therefore, it is good to prioritize sleep and rest … and [find] ways to slow down when you can."

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store